References
1. Tong X, Yang Q, Ritchey MD, George MG, Jackson SL, Gillespie C, et al. The burden of cerebrovascular disease in the United States. Prev Chronic Dis 2019;16(52):180411.
2. Terentes-Printzios D, Vlachopoulos C, Xplanteris P, Ioakeimidis N, Aznaouridis K, et al. Cardiovascular risk factors accelerate progression of vascular aging in the general population: Results from CRAVE study (Cardiovascular Risk Factors Affecting Vascular Age). Hypertension 2017;70(5):1057–64.
3. Hall John. Guyton and Hall Textbook of Medical Physiology 12th ed.th ed. Korea: Bupmoon Education; 2017.
4. Poupel L, Combadiere C. Atherosclerosis: on the trail of chemokines. Biol Aujourdhui 2010;204(4):285–93.
5. Munteanu AI, Raica M, Zota EG. Immunohistochemical study of the role of mast cells and macrophages in the process of angiogenesis in the atherosclerotic plaques in patients with metabolic syndrome. Arkh Patol 2016;78(2):19–28.
6. Chati A, Eckel RH. Lipids, lipoproteins, and cardiovascular disease: Clinical pharmacology now and in the future. J Clin Endocrinol Metab 2016;101(3):804–14.
7. Pigarevsky PV, Snegova VA, Nazarov PG. Macrophages and their role in destabilization of an atherosclerotic plaque. Kardiologiia 2019;59(4):88–91.
8. Saqib U, Sarkar S, Suk K, Mohammad O, Baig MS, Savai R. Phytochemicals as modulators of M1–M2 macrophages in inflammation. Oncotarget 2018;9(25):17937–50.
9. Liu Y, Wang X, Pang J, Zhang H, Luo J, Qian X, et al. Protocatechuic acid attenuates atherosclerosis by inhibiting M1 and promoting M2 macrophage polarization. J Agric Food Chem 2019;67(3):807–18.
10. 전국한의과대학 심계내과학교실. 東醫心系內科學 서울: 서원당; 2001.
11. 이학로. 금궤요략의 순환구조 대전: 주민출판사; 2000.
12. Ren Y, Chen ZQ, Zhang MZ, Guo LH, He DY. Cluster analysis of medication laws for treating coronary heart disease by distinguished veteran doctors of traditional Chinese medicine. Zhongguo Zhong Xi Yi Jie He Za Zhi 2016;36(4):411–4.
13. Bertrand MJ, Tardif JC. Inflammation and beyond: New directions and emerging drugs for treating atherosclerosis. Exper Opin Emerg Drug 2017;22(1):1–26.
14. Paseban M, Butler AE, Sahebkar A. Mechanisms of statin-induced new-onset diabetes. J Cell Physiol 2019;234(8):12441–61.
15. Harvey Richard A. Lippincott’s Illustrated Reviews: Pharmacology 6th ed.th ed. Seoul: Shinil Books; 2015.
16. Yuan H, Ma Q, Ye L, Piao G. The traditional medicine and modern medicine form natural products. Molecules 2016;29(5):559.
17. Yu X, Tang L, Wu H, Zhang X, Luo H, Guo R, et al. Trichosanthis Fructus: botany, traditional uses, phytochemistry and pharmacology. J Ethonopharmacol 2018;224:177–94.
18. Yao ZH, Qin ZF, Dai Y, Yao XS. Phytochemistry and pharmacology of Allii Macrostemonis Bulbus, a traditional Chinese medicine. Chin J Nat Med 2016;14(7):481–98.
19. 전국한의과대학 공동교재편찬위원회. 本草學 서울: 영림사; 2007.
20. Mao S, Chenf L, Wu L. Study on anticonvulsive effect of Rhizoma pinelliae. Zhong Yao Cai 2001;24(11):813–4.
21. Mimura J, Itoh K. Role of Nrf2 in the pathogenesis of atherosclerosis. Free Radic Biol Med 2015;88:221–32.
22. Ahotupa M. Oxidized lipoprotein lipids and atherosclerosis. Free Radic Res 2017;51(4):439–47.
23. Favari E, Chroni A, Tietge UJ, Zantti I, Escola-Gil JC, Bernini F. Cholesterol efflux and reverse cholesterol transport. Handb Exp Pharmacol 2015;224:181–206.
24. Libby P, Ridker PM, Hansson GK. Inflammation in Atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009;54(23):2129–38.